An issue of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) debt fell 0.8% against its face value during trading on Tuesday. The high-yield issue of debt has a 5.125% coupon and is set to mature on July 1, 2022. The bonds in the issue are now trading at $102.00 and were trading at $103.00 one week ago. Price moves in a company’s debt in credit markets often anticipate parallel moves in its share price.
Several brokerages have weighed in on ACHC. Mizuho upped their target price on Acadia Healthcare from $57.00 to $60.00 and gave the stock a “buy” rating in a research report on Friday, July 28th. BMO Capital Markets began coverage on Acadia Healthcare in a research report on Monday, October 16th. They issued an “outperform” rating and a $52.00 target price on the stock. Jefferies Group LLC set a $42.00 target price on Acadia Healthcare and gave the stock a “buy” rating in a research report on Wednesday, October 25th. Craig Hallum reaffirmed a “buy” rating and issued a $65.00 target price (up from $52.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. Finally, Zacks Investment Research lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, October 2nd. Two analysts have rated the stock with a sell rating, five have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $47.46.
Shares of Acadia Healthcare Company, Inc. (NASDAQ ACHC) traded up 0.10% on Tuesday, hitting $31.36. The stock had a trading volume of 2,215,692 shares. The firm’s 50 day moving average is $43.53 and its 200-day moving average is $45.93. Acadia Healthcare Company, Inc. has a one year low of $30.69 and a one year high of $54.34. The stock has a market capitalization of $2.76 billion, a PE ratio of 344.62 and a beta of 1.07.
Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.07). Acadia Healthcare had a return on equity of 8.57% and a net margin of 6.07%. The company had revenue of $716.70 million for the quarter, compared to the consensus estimate of $728.86 million. During the same quarter in the previous year, the company posted $0.58 EPS. The business’s revenue was down 2.4% on a year-over-year basis. Equities research analysts expect that Acadia Healthcare Company, Inc. will post $2.26 earnings per share for the current fiscal year.
In other Acadia Healthcare news, President Brent Turner sold 206,252 shares of the business’s stock in a transaction that occurred on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total transaction of $10,454,913.88. Following the transaction, the president now owns 81,106 shares of the company’s stock, valued at $4,111,263.14. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Christopher L. Howard sold 16,762 shares of the business’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $52.47, for a total value of $879,502.14. Following the transaction, the executive vice president now directly owns 200,999 shares in the company, valued at approximately $10,546,417.53. The disclosure for this sale can be found here. Insiders have sold 1,842,802 shares of company stock worth $93,443,510 in the last quarter. 11.10% of the stock is currently owned by corporate insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. State Board of Administration of Florida Retirement System increased its position in Acadia Healthcare by 3.8% during the third quarter. State Board of Administration of Florida Retirement System now owns 68,264 shares of the company’s stock worth $3,260,000 after buying an additional 2,470 shares during the last quarter. Frontier Capital Management Co. LLC increased its position in Acadia Healthcare by 10.2% during the third quarter. Frontier Capital Management Co. LLC now owns 2,565,442 shares of the company’s stock worth $122,526,000 after buying an additional 237,379 shares during the last quarter. Palisade Capital Management LLC NJ increased its position in Acadia Healthcare by 46.0% during the third quarter. Palisade Capital Management LLC NJ now owns 235,099 shares of the company’s stock worth $11,228,000 after buying an additional 74,085 shares during the last quarter. NJ State Employees Deferred Compensation Plan acquired a new position in Acadia Healthcare during the third quarter worth approximately $478,000. Finally, American Assets Investment Management LLC increased its position in Acadia Healthcare by 11.4% during the third quarter. American Assets Investment Management LLC now owns 84,370 shares of the company’s stock worth $4,030,000 after buying an additional 8,650 shares during the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
What are top analysts saying about Acadia Healthcare Company Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Acadia Healthcare Company Inc. and related companies.